To access this element change to forms mode OFF
Grant Award View - GA30067
I-ACT: Phase I trial of Amnion Cell Therapy for Ischaemic Stroke to...
GA ID:
GA30067
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$711,031.90
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
I-ACT: Phase I trial of Amnion Cell Therapy for Ischaemic Stroke to establish the maximum tolerable dose
Purpose:
Ischaemic stroke, resulting from an obstructive clot, comprised approximately 85 percent of all strokes. There are several new therapies including the clot-busting drug, and clot retrieval (ECR) for large clots . However, only a small subset of patients are eligible for these therapies. We have demonstrated that human amnionic stem cell can reduce stroke size in animal experiments. We thus propose a Phase 1 dose escalation trial to assess the safety of allogeneic stem cell in stroke patients.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1163282
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA